Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Optimal particle size of radiocolloid for sentinel node identification in breast cancer — Electron microscopic study and clinical comparison

Abstract

Background

Sentinel node (SN) biopsy using a radiotracer is easy to learn, reproducible, and performed by the majority of breast cancer surgeons. However, this technique raises the question: what is the optimal particle size of colloid?

Methods

Patients were injected with conventional tin colloid (median particle diameter: 700 nm) and the predominant particle size of radiocolloid retained in the SN was measured using electron microscopy. This showed a narrow distribution of colloidal size (100–150 nm). Patients were then injected with modified tin colloid having a median particle size of 100 nm. A clinical comparison was performed between conventional particle size or reduced particle size tin colloid and the SN biopsy success rate, the number of SNs, and the colloidal uptake in SNs.

Results

A total of 118 patients were injected with the conventional tin colloid (group I) and 124 patients with the smaller particle colloid (group II). The identification rate and the number of SN in both groups were almost equal, and the patients with low-uptake SNs were not significantly less in group I (p = 0.55).

However, in the subgroup of patients 60 years of age or more, group II had significantly more SNs than group I (1.4 vs 1.9;p = 0.03) and low-uptake SNs were significantly less common than in group I (0 = 0.02).

Conclusions

The improvement of colloidal uptake in SNs using the smaller particle size tin colloid was confirmed, and this impact was statistically significant in the older population.

This is a preview of subscription content, log in to check access.

References

  1. 1)

    Krag D, Weaver D, Ashikaga T, Moffat F, Himberg VS, Shriver C, Feldman S, Kusminsky R, Gadd M, Kuhn J, Harlow S, Beitsch P: The sentinel node in breast cancer-a multicenter validation study.N Engl J Med 339:941–946, 1998.

  2. 2)

    Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, Intra M, Veronesi P, Robertson C, Maisonneuve P, Renne G, De Cicco C, De Lucia F, Gennari R: A randomized comparison of sentinelnode biopsy with routine axillary dissection in breast cancer.N Engl J Med 349:546–553, 2003.

  3. 3)

    Lucci A Jr, Kelemen PR, Miller C 3rd, Chardkoff L, Wilson L: National practice patterns of sentinel lymph node dissection for breast carcinoma.J Am Coll Surg 192:453–458, 2001.

  4. 4)

    Sato K, Tamaki K, Shigekawa T, Tsuda H, Kosuda S, Kusano S, Hiraide H, Mochizuki H: Clinicopathologic and technical factors associated with the uptake of radiocolloid by sentinel nodes in patients with breast cancer.Surg Today 33:403–407, 2003.

  5. 5)

    Motomura K, Komoike Y, Inaji H, Hasegawa Y, Kasugai T, Noguchi S, Koyama H: Patient age affects identification rate of sentinel nodes in breast cancer.Biomed Pharmacother 56 (Suppl 1):209s-212s, 2002.

  6. 6)

    O’Hea BJ, Hill AD, El-Shirbiny AM, Yeh SD, Rosen PP, Coit DG, Borgen PI, Cody HS 3rd: Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center.J Am Coll Surg 186:423–427, 1998.

  7. 7)

    Kitagawa Y, Ohgami M, Fujii H, Mukai M, Ando N, Kubota T: Sentinel node mapping in gastrointestinal cancer: Radio-guided method and dye method.Gastroenterol Surg 23:1611–1615, 2000.

  8. 8)

    Uenosono Y, Natsugoe S, Higashi H, Ehi K, Miyazono F, Ishigami S, Hokita S, Aikou T: Evaluation of colloid size for sentinel nodes detection using radio-isotope in early gastric cancer.Cancer Lett 200:19–24, 2003.

  9. 9)

    Sato K, Tamaki K, Tsuda H, Kosuda S, Kusano S, Hiraide H, Mochizuki H: Utility of Axillary Ultrasound Examination to Select Breast Cancer Patients Suited for Optimal Sentinel Node Biopsy.Am J Surg 87:679–683, 2004.

  10. 10)

    Cody HS 3rd, Fey J, Akhurst T, Fazzari M, Mazumdar M, Yeung H, Yeh SD, Borgen PI: Complementarity of blue dye and isotope in sentinel node localization for breast cancer: univariate and multivariate analysis of 966 procedures.Ann Surg Oncol 8:13–19, 2001.

  11. 11)

    Cortes RM, Bajen MT, Fernandez LA, Benito E, Azpeitia D, Prieto L, Moreno A, Ricart Y, Escobedo A, Martin CJ: Sentinel lymph node (SN) detection in patients with breast cancer influence of tumor size and age of the patient.Rev Esp Med Nucl 23:3–8, 2004 (in Spanish with English abstract).

  12. 12)

    Sato K, Hiraide H, Uematsu M, Tamaki K, Ishikawa H, Yamasaki T, Tamai S, Kusano S, Mochizuki H: Efficacy and Significance of Sentinel Lymph Node Identification with Technetium-99m-labeled Tin Colloids for Breast Cancer.Breast Cancer 5:389–393, 1998.

  13. 13)

    Sato K, Uematsu M, Saito T, Ishikawa H, Yamasaki T, Tamaki K, Tamai S, Kusano S, Hiraide H, Mochizuki H: Indications and technique of sentinel lymph node biopsy in breast cancer using 99m-technetium labeled tin colloids.Breast Cancer 7:95–98, 2000.

  14. 14)

    Sato K, Uematsu M, Saito T, Ishikawa H, Tamaki K, Tamai S, Wong JR, Kusano S, Hiraide H, Mochizuki H: Sentinel lymph node identification for patients with breast cancer using large-size radiotracer particles.Breast J 7:388–391, 2001.

  15. 15)

    Sato K, Tamaki K, Shigekawa T, Tsuda H, Kosuda S, Kusano S, Hiraide H, Mochizuki H: Clinically useful detection criteria for sentinel nodes in patients with breast cancer using a radioisotope technique.Jpn J Clin Oncol 32:403–406, 2002.

  16. 16)

    Cox CE, Pendas S, Cox JM, Joseph E, Shons AR, Yeatman T, Ku NN, Lyman GH, Berman C, Haddad F, Reintgen DS: Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer.Ann Surg 227:645–653, 1998.

  17. 17)

    McMasters KM, Turtle TM, Carlson DJ, Brown CM, Noyes RD, Glaser RL, Vennekotter DJ, Turk PS, Tate PS, Sardi A, Cerrito PB, Edwards MJ: Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used.J Clin Oncol 18:2560–2566, 2000.

  18. 18)

    Veronesi U, Paganelli G, Viale G, Galimberti V, Luini A, Zurrida S, Robertson C, Sacchini V, Veronesi P, Orvieto E, De Cicco C, Intra M, Tosi G, Scarpa D: Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series.J Natl Cancer Inst 91:368–373, 1999.

  19. 19)

    Giuliano AE, Jones RC, Brennan M, Statman R: Sentinel lymphadenectomy in breast cancer.J Clin Oncol 15:2345–2350, 1997

  20. 20)

    Ahrendt GM, Laud P, Tjoe J, Eastwood D, Walker AP, Otterson MF, Redlich PN: Does breast tumor location influence success of sentinel lymph node biopsy?J Am Coll Surg 194:278–284, 2002.

  21. 21)

    Vargas HI, Vargas MP, Venegas R, Gonzalez KD, Burla M, Mishkin F, Khalkhali I: Lymphatic tumor burden negatively impacts the ability to detect the sentinel lymph node in breast cancer.Am Surg 69:886–890, 2003.

  22. 22)

    Motomura K, Inaji H, Komoike Y, Kasugai T, Nagumo S, Hasegawa Y, Koyama H: Gamma probe and ultrasonographically-guided fine-needle aspiration biopsy of sentinel lymph nodes in breast cancer patients.Eur J Surg Oncol 27:141–145, 2001.

  23. 23)

    de Kanter AY, van Eijck CH, van Geel AN, Kruijt RH, Henzen SC, Paul MA, Eggermont AM, Wiggers T: Multicentre study of ultrasonographically guided axillary node biopsy in patients with breast cancer.Br J Surg 86:1459–1462, 1999.

  24. 24)

    Deurloo EE, Tanis PJ, Gilhuijs KG, Muller SH, Kroger R, Peterse JL, Rutgers EJ, Valdes OR, Schultze KLJ: Reduction in the number of sentinel lymph node procedures by preoperative ultrasonography of the axilla in breast cancer.Eur J Cancer 39:1068–1073, 2003.

  25. 25)

    Bedrosian I, Bedi D, Kuerer HM, Fornage BD, Harker L, Ross MI, Ames FC, Krishnamurthy S, Edeiken-Monroe BS, Meric F, Feig BW, Akins J, Singletary SE, Mirza NQ, Hunt KK: Impact of clinicopathological factors on sensitivity of axillary ultrasonography in the detection of axillary nodal metastases in patients with breast cancer.Ann Surg Oncol 10:1025–1030, 2003.

  26. 26)

    Miyauchi M, Yamamoto N, Imanaka N, Matsumoto M: Computed tomography for preoperative evaluation of axillary nodal status in breast cancer.Breast Cancer 6:243–248, 1999.

  27. 27)

    Suzuma T, Sakurai T, Yoshimura G, Umemura T, Tamaki T, Yang QF, Oura S, Naito Y: MR-axfflography oriented surgical sampling for assessment of nodal status in the selection of patients with breast cancer for axillary lymph nodes dissection.Breast Cancer 9:69–74, 2002.

  28. 28)

    Cox CE, Dupont E, Whitehead GF, Ebert MD, Nguyen K, Peltz ES, Peckham D, Cantor A, Reintgen DS: Age and body mass index may increase the chance of failure in sentinel lymph node biopsy for women with breast cancer.Breast J 8:88–91, 2002.

  29. 29)

    Derossis AM, Fey JV, Cody HS 3rd, Borgen PI: Obesity influences outcome of sentinel lymph node biopsy in early-stage breast cancer.J Am Coll Surg 197:896–901, 2003.

  30. 30)

    Strand SE, Bergqvist L: Radiolabeled colloids and macromolecules in the lymphatic system.Crit Rev Ther Drug Carrier Syst 6:211–238, 1989.

  31. 31)

    Watanabe T, Kimijima I, Ohtake T, Tsuchiya A, Shishido F, Takenoshita S: Sentinel node biopsy with technetium-99m colloidal rhenium sulphide in patients with breast cancer.Br J Surg 88:704–707, 2001.

  32. 32)

    Noguchi M: Sentinel lymph node biopsy in breast cancer: an overview of the Japanese experience.Breast Cancer 8:184–194, 2001.

  33. 33)

    Tanis PJ, Nieweg OE, Valdes ORA, Kroon BB: Anatomy and physiology of lymphatic drainage of the breast from the perspective of sentinel node biopsy.J Am Coll Surg 192:399–409, 2001.

  34. 34)

    Albertini JJ, Lyman GH, Cox C, Yeatman T, Balducci L, Ku N, Shivers S, Berman C, Wells K, Rapaport D, Shons A, Horton J, Greenberg H, Nicosia S, Clark R, Cantor A, Reintgen DS: Lymphatic mapping and sentinel node biopsy in the patient with breast cancer.JAMA 276:1818–1822, 1996.

  35. 35)

    Krag DN, Weaver DL, Alex JC, Fairbank JT: Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe.Surg Oncol 2:335–340, 1993.

  36. 36)

    Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M, Costa A, de Cicco C, Geraghty JG, Luini A, Sacchini V, Veronesi P: Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.Lancet 349:1864–1867, 1997.

  37. 37)

    Borgstein PJ, Pijpers R, Comans EF, van Diest PJ, Boom RP, Meijer S: Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 186:275–283, 1998.

  38. 38)

    Jinno H, Ikeda T, Matsui A, Kitagawa Y, Kitajima M, Fujii H, Nakamura K, Kubo A: Sentinel lymph node biopsy in breast cancer using technetium-99m tin colloids of different sizes.Biomed Pharmacother 56:213–216, 2002.

  39. 39)

    Cody HS 3rd: Sentinel lymph node mapping in breast cancer.Oncology 13:25–36, 1999.

  40. 40)

    Ikomi F, Hanna GK, Schmid-schonbein GW: Mechanism of colloidal particle uptake into the lymphatic system: basic study with percutaneous lymphography.Radiology 196:107–113, 1995.

Download references

Author information

Correspondence to Kazuhiko Sato or David Krag or Kuniyoshi Tamaki or Mikio Anzai or Hitoshi Tsuda or Shigeru Kosuda or Shoichi Kusano or Hoshio Hiraide or Hidetaka Mochizuki.

About this article

Cite this article

Sato, K., Krag, D., Tamaki, K. et al. Optimal particle size of radiocolloid for sentinel node identification in breast cancer — Electron microscopic study and clinical comparison. Breast Cancer 11, 256 (2004). https://doi.org/10.1007/BF02984546

Download citation

Key words

  • Sentinel node
  • Breast cancer
  • Tin colloid
  • Particle size
  • Electron microscopy